Jaguar Health, Inc. has initiated the commercial launch of Neonorm Dog, a non-prescription, plant-based product designed to support normal stool consistency and GI fluid balance in dogs, extending its Neonorm franchise beyond foals and calves. The company expects the product to be available soon through Amazon and Chewy, broadening its footprint in the companion animal market. Neonorm Dog contains a standardized botanical extract from the sustainably harvested Croton lechleri tree, which acts locally in the gut. Jaguar's Chief Business Officer Ian Wendt highlighted the product as a science-backed alternative to home remedies, and CEO Lisa Conte emphasized its role in managing common digestive episodes in dogs. The launch targets the large dog-owning populations in the United States and Europe, aiming to reach pet owners, veterinarians, and animal health retailers seeking non-antibiotic options.
Jaguar Animal Health IncJaguar Health launches a new product, Neonorm Dog, expanding its franchise and market reach.
Amazon.com Inc
Chewy Inc